Search
Navicixizumab
go.drugbank.com/drugs/DB12634InvestigationalNavicixizumab is under investigation in clinical trial NCT02298387 (A Phase 1 Study of Navicixizumab in Subjects With Solid Tumors).
Tocotrienol
go.drugbank.com/drugs/DB12647InvestigationalTocotrienol has been investigated for the treatment of Cholesterol Lowering.
Categories: Compounds used in a research, industrial, or household settingJNJ-42396302
go.drugbank.com/drugs/DB12657InvestigationalJnj 42396302 is under investigation in clinical trial NCT01732237 (A Study to Investigate the Pharmacokinetics of JNJ-42396302, JNJ-53773187 and JNJ-42692507 in Healthy Male Participants).
Indantadol
go.drugbank.com/drugs/DB12664InvestigationalIndantadol has been used in trials studying the treatment of Cough and Diabetic Peripheral Neuropathic Pain.
Categories: Monoamine Oxidase A Inhibitors for interaction with Monoamine Oxidase A substratesLurbinectedin
go.drugbank.com/drugs/DB12674ApprovedInvestigationalLurbinectedin is a DNA alkylating agent that has been investigated in the treatment of a variety of cancers, including mesothelioma,[A214325] chronic lymphocytic leukemia (CLL),[A214328] breast cancer, … the substitution of the tetrahydroisoquinoline with a tetrahydro β‐carboline that results in increased antitumour activity of lurbinectedin as compared to its predecessor.
UK-432097
go.drugbank.com/drugs/DB12691InvestigationalUK-432,097 has been used in trials studying the treatment of Pulmonary Disease, Chronic Obstructive.
Categories: Adenosine A receptor agonistsMethylselenocysteine
go.drugbank.com/drugs/DB12697InvestigationalMethylselenocysteine has been used in trials studying the prevention of Prostate Carcinoma and No Evidence of Disease.
Synonyms: SE-METHYL-SELENO-L-CYSTEINECategories: Compounds used in a research, industrial, or household settingVelusetrag
go.drugbank.com/drugs/DB12702InvestigationalIt is a highly selective serotonin receptor agonist effective in patients with chronic constipation. It is being developed by Theravance. … Velusetrag was discovered by Theravance through the application of its multivalent drug design in a research program dedicated to finding new treatments for GI motility disorders.
Sotagliflozin
go.drugbank.com/drugs/DB12713ApprovedInvestigational1 diabetes mellitus (T1DM) and a BMI ≥27 kg/m<sup>2</sup>. … [L39734] A similar approval has also been sought in the US, but the FDA has since published a proposal to refuse the approval because the data submitted did not show that it was safe under the proposed
NB-001
go.drugbank.com/drugs/DB12716InvestigationalNB-001 has been investigated for the treatment of Recurrent Herpes Labialis.